PADI4 and colitis: Cl-amidine, an irreversible PAD4 inhibitor, has demonstrated strong efficacy in TNBS-induced colitis by reducing NET formation, lowering colonic PAD4 and Cit-H3 levels, and improving clinical disease scores [287].